Shares of Glenmark Pharmaceuticals struck a fresh high
Advertisement
Advertisement
Glenmark said its US unit has been granted final approval by the United States Food and Drug Administration for Drospirenone and Ethinyl Estradiol Tablets USP, 3mg/0.02 mg, the generic version of Yaz Tablets of Bayer HealthCare Pharmaceuticals Inc.
As a consequence, Glenmark added 50 rupees, or 4.4 percent, to 1209.80 rupees on the National Stock Exchange where 11 lakh shares were traded compared with a 5-day average of 16.6 lakh shares.
Glenmark's market capitalisation has gained 68 percent in the past one year to 33,800 crore rupees as investors preferred the relative predictability of pharma revenues. The stock trades 8 times book value of 146 rupees.
Image credit: Indiatimes
Advertisement
Advertisement
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
- Catan adds climate change to the latest edition of the world-famous board game
- Tired of blatant misinformation in the media? This video game can help you and your family fight fake news!
- Tired of blatant misinformation in the media? This video game can help you and your family fight fake news!
- JNK India IPO allotment – How to check allotment, GMP, listing date and more
- Indian Army unveils selfie point at Hombotingla Pass ahead of 25th anniversary of Kargil Vijay Diwas